Yazar "Verheggen, Bram" seçeneğine göre listele
Listeleniyor 1 - 1 / 1
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe PDB100 - Cost-Effectiveness of Exenatide Twice Daily (Bid) Added To Basal Insulin Compared To A Bolus Insulin Add-On In Turkey(Elsevier Science Inc, 2014) Malhan, Berna Simten; Güler, Serdar; Yetkin, İlhan; Baeten, Steef; Verheggen, BramObjectives Type 2 diabetes (T2D) patients on basal insulin with uncontrolled HbA1c levels often receive an add-on with bolus insulin to lower HbA1c levels. The aim of this analysis is to estimate long-term cost-effectiveness of treating T2D patients with – a recently introduced – twice daily (BID) exenatide add-on to basal insulin strategy from a Turkish health care perspective.
